Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Work-related problems in multiple sclerosis: a literature review on its associates and determinants.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies.
A mechanism-based classification of pain in multiple sclerosis.
Anorectal dysfunction in multiple sclerosis: a systematic review.
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Pages
« first
‹ previous
…
271
272
273
274
275
276
277
278
279
…
next ›
last »